Illucidx Ultra-Sensitive Diagnostics
medical devices
About
Headquartered in Calgary, Alberta, Canada we hope to enable broad access to the technology of ultrasensitive diagnostics tools for resource-limited settings across the globe. We are currently working on a cartridge-based COVID-19 test to provide much needed rapid and accurate diagnostics in the fight against the globals COVID-19 pandemic. Illucidx continues to perfect our ultra-sensitive near-patient malaria diagnostics designed for deployment in malaria-endemic resource-limited countries.
Technologies
Google Cloud HostingMobile FriendlyVarnishWix
Keywords
biosensor integrationcost-effective diagnostic toolsdiagnostic chemistry developmentbiosensor technologyhigh throughput diagnostic chemistrycovid-19 dxbiosensor developmentfield deployable testscovid-19 rapid testingfield diagnostics for tropical diseasesdiagnostic cartridgesclinical outcomesbiomaterialsservicesnucleic acid testingbiosensor validationlamp/isothermal amplificationpoint-of-care molecular testingbiotechnologyultra-sensitive diagnosticsbiosensor testingsample extractionisothermal amplification for infectious diseasesmalaria detection in low-resource settingsbiosensor fabricationshelf-stable diagnostic testspathogen detectionhealthcare technologyrapid diagnosticslow-cost diagnostic solutions
Company Information
- Employees1
- Founded2019
Location
Calgary, Alberta, Canada, T2L 1Y8
